1 / 18

AngioMatTrain FP7-PEOPLE-2012-ITN Overview of Work Packages and Status

hjhhkhkkhkhk. AngioMatTrain FP7-PEOPLE-2012-ITN Overview of Work Packages and Status. Research Summer School 1-Crete 16 th May 2014. Work Packages (WP). WP1 Research. WP2 Research. WP3 Research. WP4 Research. WP5 Education and Training. WP6 Dissemination and Outreach. WP7

alvin-wyatt
Download Presentation

AngioMatTrain FP7-PEOPLE-2012-ITN Overview of Work Packages and Status

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. hjhhkhkkhkhk AngioMatTrainFP7-PEOPLE-2012-ITNOverview of Work Packages and Status Research Summer School 1-Crete 16th May 2014

  2. Work Packages (WP) WP1 Research WP2 Research WP3 Research WP4 Research WP5 Education and Training WP6 Dissemination and Outreach WP7 Management

  3. Timeline of AngioMatTrain Project - Gantt Chart May 2014 Start Date: 1st May 2013; End Date 30th April 2017

  4. Work Package 1 D1: Synthesis of recombinant elastin M1: Selection of the optimum hydrogel fabrication protocol D2: Development of a ‘natural mimic’ hydrogel D3: A hydrogel with precise control over cellular microenvironments M2: Selection of optimum reservoir system fabrication method D4: Nano/microspherical reservoir system loaded in biomimetichydrogel ESR1 ESR5 ESR6 ESR8 ESR9 ESR12 ER2 Structural Architecture for Design of Reservoir-based Biodegradable Scaffolds

  5. Work Package 2 ESR1 D5: ELPs with designed motifs specific to the angiogenic response M3: pH and MMP sensitive linker designed D6: Micro/nanospheres tethered with angiogenic and anti inflammatory mediators through a pH and MMP sensitive linker and its therapeutic efficacy in vitro will be quantified M4: Optimal hydrogel characterised in vitro D7: Spatial and temporal distribution of micro/nanospheres in the hydrogel system will be optimised in an in vitro model system ESR2 ESR3 ESR4 ESR6 ESR8 ESR10 ESR11 Functionalisation of Scaffolds with Angiogenic Factors using Linking Systems

  6. Work Package 3 D8: Functionalised angiogenic hydrogel system that can enhance angiogenesis in a preclinical model of myocardial infarction D9: Functionalised angiogenic hydrogel system that can enhance angiogenesis in a preclinical model of limb ischemia ESR1 ESR8 ESR2 ESR9 ESR4 ESR10 ESR5 ESR11 ESR6 ESR12 ESR7 ER3 ER1 Investigating In Vivo Response of Responsive Angiogenic Scaffolds for Ischemic Repair

  7. Work Package 4 ESR1 ESR2 ESR4 D10: Protocols for developing in vivo models for ischemia D11: Device for delivery of multicomponent hydrogel designed and tested ESR5 ESR8 ESR9 ESR12 ER2 ER3 Scale-up and Design of Delivery Systems to Ischemic Sites

  8. Education and Training-WP5 (NUIG)

  9. Early Stage Researchers (ESRs) * Original proposed start date

  10. Experienced Researchers (ERs)

  11. Research Summer School 2 Tissue Engineering and Regenerative Medicine I Venue: Spain Date: Oct 20th to 24th 2014 Lectures, Interactive Workshops, Practicals, Best Media Contests, Networking Mid-term Review Date Discussion

  12. Dissemination and Outreach-WP6 (NUIG)

  13. Dissemination and Outreach-WP6 (NUIG) D19 AngiomatTrain Website:

  14. Dissemination and Outreach-WP6 (NUIG) D20 AngiomatTrain Promotional Flyer:

  15. Dissemination and Outreach-WP6 (NUIG) Outreach Activities: http://www.youtube.com/watch?v=rrv_wx27qwQ

  16. Management-WP7 (NUIG)

  17. Reporting 12 month Progress Report is due within 30 days after M12-May 30th 2014 Template for Progress Report was circulated

  18. Other Business Consortium Agreement Amendment to Grant Agreement for electronic-only signature and transmission of Forms C, D, and E Mid-term Review structure and date

More Related